Virus DNA left on a hospital bed rail was found in nearly half of all sites sampled across a ward within 10 hours and persisted for at least five days, according to a new study by UCL and Great Ormond Street Hospital (GOSH).
The study, published as a letter in the Journal of Hospital Infection, aimed to safely simulate how SARS-CoV-2, the virus that causes Covid-19, may spread across surfaces in a hospital.
Instead of using the SARS-CoV-2 virus, researchers artificially replicated a section of DNA from a plant-infecting virus, which cannot infect humans, and added it to a milliliter of water at a similar concentration to SARS-CoV-2 copies found in infected patients’ respiratory samples.
HAVANA HAVANA (Reuters) — Communist-run Cuba said this week that use of two drugs produced by its biotech industry that reduce hyper-inflammation in seriously ill COVID-19 patients has sharply curbed its coronavirus-related death toll.
Health authorities have reported just two virus-related deaths over the past nine days among more than 200 active cases on the Caribbean’s largest island, a sign they may have the worst of the outbreak under control.
The government, which hopes to increase its biopharmaceutical exports, has touted various drugs it produces for helping prevent infection with the new coronavirus and treating the COVID-19 disease it causes.
Norwegian scientist Birger Sørensen has claimed the novel coronavirus SARS-CoV-2 is not natural in origin. The claims by the co-author of the British-Norwegian study—published in the Quarterly Review of Biophysics —are supported by the former head of Britain’s MI6, Sir Richard Dearlove.
The study from Sørensen and British professor Angus Dalgleish show that the coronavirus’s spike protein contains sequences that appear to be artificially inserted.
They also highlight the lack of mutation since its discovery, which suggests it was already fully adapted to humans. The study goes on to explain the rationale for the development of Biovacc-19, a candidate vaccine for COVID-19 that is now in advanced pre-clinical development.
Researchers at Tufts University’s School of Engineering have developed biomaterial-based inks that respond to and quantify chemicals released from the body (e.g. in sweat and potentially other biofluids) or in the surrounding environment by changing color. The inks can be screen printed onto textiles such as clothes, shoes, or even face masks in complex patterns and at high resolution, providing a detailed map of human response or exposure. The advance in wearable sensing, reported in Advanced Materials, could simultaneously detect and quantify a wide range of biological conditions, molecules and, possibly, pathogens over the surface of the body using conventional garments and uniforms.
“The use of novel bioactive inks with the very common method of screen printing opens up promising opportunities for the mass-production of soft, wearable fabrics with large numbers of sensors that could be applied to detect a range of conditions,” said Fiorenzo Omenetto, corresponding author and the Frank C. Doble Professor of Engineering at Tufts’ School of Engineering. “The fabrics can end up in uniforms for the workplace, sports clothing, or even on furniture and architectural structures.”
Wearable sensing devices have attracted considerable interest in monitoring human performance and health. Many such devices have been invented incorporating electronics in wearable patches, wristbands, and other configurations that monitor either localized or overall physiological information such as heart rate or blood glucose. The research presented by the Tufts team takes a different, complementary approach—non-electronic, colorimetric detection of a theoretically very large number of analytes using sensing garments that can be distributed to cover very large areas: anything from a patch to the entire body, and beyond.
By drawing inspiration from the structures and functionalities of squid skin cells, a team of researchers designed and engineered human cells that contain stimuli-responsive photonic architectures and, as a consequence, possess the ability to change their appearance and transmission of light.
This work on one-cell embryos could advance our knowledge of the mechanisms that underpin cellular behaviour in general, and may ultimately provide insights into what goes wrong in aging and disease.
For the first time, scientists have added microscopic tracking devices into the interior of cells, giving a peek into how development starts.
Like all countries, China is facing severe economic losses from the pandemic, and that will certainly have a negative impact on scientific research, because funding will be reduced and projects will be delayed, says physicist Wang Yifang, director of the Institute of High Energy Physics in Beijing. Some universities have already announced a cut in funding. The research budget given by the education ministry to Jiangnan University in Wuxi, for example, will drop by more than 25% for 2020, and other universities are facing similar reductions. “An overall budget cutting of government spending on higher education is highly possible, though the level and scope may vary by regions, universities and fields,” says Tang Li, a science-policy scientist at Fudan University in Shanghai.
The country is rapidly gaining on the United States in research, but problems could slow its rise: part 5 in a series on science after the pandemic.
When it comes to monitoring electrical activity in the brain, patients typically have to lie very still inside a large magnetoencephalography (MEG) machine. That could be about to change, though, as scientists have developed a new version of a wearable helmet that does the same job.
Back in 2018, researchers at Britain’s University of Nottingham revealed the original version of their “MEG helmet.”
The 3D-printed device was fitted with multiple sensors that allowed it to read the tiny magnetic fields created by brain waves, just like a regular MEG machine. Unlike the case with one of those, however, wearers could move around as those readings were taking place.
A team of researchers from several U.S. institutions has created an organoid culture system that generates complex skin from human pluripotent stem cells.
